Title: Pei-Hua Lin: Innovator in Antibody Research
Introduction: Pei-Hua Lin is a prominent inventor based in Shanghai, China. She is currently associated with Shanghai Henlius Biotech Inc., where she contributes to the field of biotechnology. Although she has not yet been granted any patents, her work focuses on developing innovative antibody therapies.
Latest Patent Applications: Pei-Hua Lin has been involved in several significant patent applications. One of her latest applications is titled "Anti-PDL1 Antibodies, Multispecific Antibodies and Methods of Use." This application relates to antibodies and antibody derivatives that bind to PDL1, along with methods for their use. In certain embodiments, the disclosed antibody or antibody derivative comprises a single domain antibody that binds to PDL1. Additionally, the application includes a multispecific antibody that binds to PDL1 and an additional antigen, such as CD47. Another application is titled "Anti-PDL1 Antibodies and Methods of Use," which also focuses on antibodies and antibody derivatives that bind to PDL1.
Conclusion: Pei-Hua Lin is making strides in the field of antibody research, with her innovative applications aimed at addressing critical medical needs. Her contributions to Shanghai Henlius Biotech Inc. highlight her commitment to advancing biotechnology.